CovaClear IV
Commercial- Indications
- Vascular access infections
Company intelligence / Profile preview
Covalon’s products are commercialized globally with adoption in major pediatric hospitals. Their advanced collagen matrix dressings have demonstrated clinical advantages in chronic/infected wound healing—helping avoid amputations—and their dual-antimicrobial silicone vascular access dressing reduces infections and pain during use. The company’s solutions are validated by leading hospitals worldwide.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Covalon Technologies.